U.S. plans to invest billions in manufacturing COVID-19 vaccine
Send a link to a friend
[November 17, 2021]
WASHINGTON (Reuters) - The United States is
planning to invest billions of dollars in expanding COVID-19
manufacturing capacity to have at least a billion doses by the second
half of next year, the New York Times reported on Wednesday, citing top
White House advisers.
|
The announcement to be made Wednesday comes as the administration of
President Joe Biden faces pressure from activists to increase the
vaccine supply to poorer countries.
The investment in vaccine production is part of a private-public
partnership to address vaccine needs at home and around the world
and also to prepare for future pandemics, Dr. David Kessler, who
oversees vaccine distribution, and Jeff Zients, the White House
coronavirus response coordinator, told the Times.
The plan is estimated to cost several billion dollars and will be
paid for with funds from the American Rescue Plan Biden signed into
law in March, Kessler told the Times.
![](http://archives.lincolndailynews.com/2021/Nov/17/images/ads/current/charrons_bch041713.png)
[to top of second column] |
![](http://archives.lincolndailynews.com/2021/Nov/17/images/ads/current/castlemanor_sda_FINANCIAL_2017.png) "This is about assuring
expanded capacity against COVID variants and
also preparing for the next pandemic," Kessler
told the newspaper.
"The goal, in the case of a future pandemic, a
future virus, is to have vaccine capability
within six to nine months of identification of
that pandemic pathogen, and to have enough
vaccines for all Americans," he said.
(Reporting by Doina Chiacu; Editing by Chizu
Nomiyama)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |